Debridement of the noninfected wound

Journal of the American Podiatric Medical Association

Volumn 100, Issue 5, 2010, Pages 353-359

  Cornell, Rhonda S ^a   Meyr, Andrew J ^b   Steinberg, John S ^a,c   Attinger, Christopher E ^a  

^a GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TEMPLE UNIVERSITY   (United States)

^c GEORGETOWN UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 78650290118     PISSN: 87507315     EISSN: None     Source Type: Journal    
DOI: 10.7547/1000353     Document Type: Article

References (46)

1. BROUGHTON G, JANIS JE, ATTINGER CE: A brief history of wound care. Plast Reconstr Surg 117 (suppl): 6S, 2006.
2. ATTINGER CE, BULAN E, BLUME PA: Surgical debridement: the key to successful wound healing and reconstruction. Clin Podiatr Med Surg 17: 599, 2000.
3. ATTINGER CE, JANES JE, STEINBERG JS, ET AL: Clinical approach to wounds: debridement and wound bed preparation including the use of dressings and wound-healing adjuvants. Plast Reconstr Surg 117 (suppl): 72S, 2006.
4. ARMSTRONG DG, LAVERY LA, NIXON BP, ET AL: It's not what you put on, but what you take off: techniques for debriding and off-loading the diabetic foot wound. Clin Infect Dis 39 (suppl 2): S92, 2004.
5. CARDINAL M, EISENBUD DE, ARMSTRONG DG, ET AL: Serial surgical debridement: a retrospective study on clinical outcomes in chronic lower extremity wounds. Wound Repair Regen 17: 306, 2009.
6. SAAP LJ, FALANGA V: Debridement performance index and its correlation with complete closure of diabetic foot ulcers. Wound Repair Regen 10: 354, 2002.
7. KUMAGI SG, MAHONEY CR, FITZGIBBONS TC, ET AL: Treatment of diabetic (neuropathic) foot ulcers with two-stage debridement and closure. Foot Ankle Int 19: 160, 1998.
8. WILLIAMS D, ENOCH S, MILLER D, ET AL: Effect of sharp debridement using curette on recalcitrant non-healing venous leg ulcers: a concurrently controlled, prospective cohort study. Wound Repair Regen 132: 131, 2005.
9. STEED DL, DONOHOE D, WEBSTER MW, ET AL; Diabetic Ulcer Study Group: Effect of extensive debridement and treatment on the healing of diabetic foot ulcers. J Am Coll Surg 183: 61, 1996.
10. BREM H, SHEEHAN P, ROSENBERG HJ, ET AL: Evidence-based protocol for diabetic foot ulcers. Plast Reconstr Surg 117 (suppl): 193S, 2006.
11. PIAGGESI A, SCHIPANI E, CAMPI F, ET AL: Conservative surgical approach versus non-surgical management for diabetic neuropathic foot ulcers: a randomized trial. Diabet Med 15: 4412, 1998.
12. DRYBURGH N, SMITH F, DONALDSON J, ET AL: Debridement for surgical wounds. Cochrane Database Syst Rev 3: CD006214, 2008.
13. GOTTRUP F: Debridement: another evidence problem in wound healing. Wound Repair Regen 17: 294, 2009.
14. JAMES GA, SWOGGER E, WOLCOTT R, ET AL: Biofilms in chronic wounds. Wound Repair Regen 16: 37, 2008.
15. BROUGHTON G II, JANIS JE, ATTINGER CE: The basic science of wound healing. Plast Reconstr Surg 117 (suppl): 12S, 2006.
16. PANUNCIALMAN J, FALANGA V: The science of wound bed preparation. Surg Clin North Am 89: 611, 2009.
17. CLARK RA: Oxidative stress and "senescent" fibroblasts in non-healing wounds as potential therapeutic targets. J Invest Dermatol 128: 2361, 2008.
18. VANDE BERG JS, ROSE MA, HAYWOOD-REID PL, ET AL: Cultured pressure ulcer fibroblasts show replicative senescence with elevated production of plasmin, plasminogen activator inhibitor-1, and transforming growth factor-beta 1. Wound Repair Regen 13: 76, 2005.
19. ALMQVIST S, WERTHEN M, JOHANSSON A, ET AL: Evaluation of near-senescent human dermal fibroblast cell line and effect of amelgenin. Br J Dermatol 160: 1163, 2009.
20. MENDEZ MV, RAFFETTO JD, PHILLIPS T, ET AL: The proliferative capacity of neonatal fibroblasts is reduced after exposure to venous ulcer fluid: a potential mechanism for senescence in venous ulcers. J Vasc Surg 30: 734, 1999.
21. HARDING KG, MOORE K, PHILLIPS TJ: Wound chronicity and fibroblast senescence: implications for treatment. Int Wound J 2: 364, 2005.
22. STANLEY A, OSLER T: Senescence and the healing rates of venous ulcers. J Vasc Surg 33: 1206, 2001.
23. MARTIN JM, ZENILMAN JM, LAZARUS GS: Molecular microbiology: new dimensions for cutaneous biology and wound healing. J Invest Dermatol 130: 38, 2010.
24. DAVIS SC, MARTINEZ L, KIRSNER R: The diabetic foot: the importance of biofilms and wound bed preparation. Curr Diab Rep 6: 439, 2006.
25. BRADY RA, LEID JG, CALHOUN JH, ET AL: Osteomyelitis and the role of biofilms in chronic infection. FEMS Immunol Med Microbiol 52: 13, 2008.
26. COSTERTON W, VEEH R, SHIRTLIFF M, ET AL: The application of biofilm science to the study and control of chronic bacterial infections. J Clin Invest 112: 1466, 2003.
27. BREM H, GOLINK MS, STOJADINOVIC O, ET AL: Primary cultured fibroblasts derived from patients with chronic wounds: a methodology to produce human cells and test putative growth factor therapy such as GMCSF. J Transl Med 6: 75, 2008.
28. KIRSNER R: Biofilms, bioburden, and senesent cells: role of biofilms in osteomyelitis and wound failure. Paper presented at: Diabetic Limb Salvage Conference; September 24, 2009; Washington, DC.
29. BOWLING FL, STICKINGS DS, EDWARDS-JONES V, ET AL: Hydrodebridement of wounds: effectiveness in reducing wound bacterial contamination and potential for air bacterial contamination. J Foot Ankle Res 2: 13, 2009.
30. CASELLI A, LATINI V, LAPENNA A, ET AL: Transcutaneous oxygen tension monitoring after successful revascularization in diabetic patients with ischaemic foot ulcers. Diabet Med 22: 460, 2005.
31. GAME F: The advantages and disadvantages of nonsurgical management of the diabetic foot. Diabetes Metab Res Rev 24 (suppl 1): S72, 2008.
32. ENOCH S, GREY JE, HARDING KG: ABC of wound healing: non-surgical and drug treatments. BMJ 332: 900, 2006.
33. KLASEN HJ: A review of the nonoperative removal of necrotic tissue from burn wounds. Burns 26: 207, 2000.
34. DAVIES CE, TURTON G, WOOLFREY G, ET AL: Exploring debridement options for chronic venous leg ulcers. Br J Nurs 14: 393, 2005.
35. SINGHAL A, REIS ED, KERSTEIN MD: Options for nonsurgical debridement of necrotic wounds. Adv Skin Wound Care 14: 96, 2001.
36. SHERMAN RA: Maggot therapy for foot and leg wounds. Int J Low Extrem Wounds 1: 135, 2002.
37. SHERMAN RA, SHAPIRO CE, YANG RM: Maggot therapy for problematic wounds: uncommon and off-label applications. Adv Skin Wound Care 20: 602, 2007.
38. TANTAWI TI, GOHAR YM, KOTB MM, ET AL: Clinical and microbiological efficacy of MDT in the treatment of diabetic foot ulcers. J Wound Care 16: 379, 2007.
39. DUMVILLE JC, WORTHY G, BLAND JM, ET AL: VenUS II team: Larval therapy for leg ulcers (VenUS II): randomized controlled trial. BMJ 338: b773, 2009.
40. BELL AL, CAVORSI J: Noncontact ultrasound therapy for adjunctive treatment of nonhealing wounds: retrospective analysis. Phys Ther 88: 1517, 2008.
41. RAMUNDO J, GRAY M: Is ultrasonic mist therapy effective for debriding chronic wounds? J Wound Ostomy Continence Nurs 35: 579, 2008.
42. HINCHLIFFE RJ, VALK GD, APELQVIST J, ET AL: A systemic review of the effectiveness of interventions to enhance the healing of chronic ulcers of the foot in diabetes. Diabetes Metab Res Rev 24 (suppl 1): S119, 2008.
43. ENNIS WJ, FOREMANN P, MOZEN N, ET AL: Ultrasound therapy for recalcitrant diabetic foot ulcers: results of a randomized, double-blind, controlled, multicenter study. Ostomy Wound Manage 51: 24, 2005.
44. ENNIS WJ, VALDES W, GAINER M, ET AL: Evaluation of clinical effectiveness of MIST ultrasound therapy for the healing of chronic wounds. Adv Skin Wound Care 19: 437, 2006.
45. PANUNCIALMAN J, FALANGA V: The science of wound bed preparation. Clin Plast Surg 34: 621, 2007.
46. SHEEHAN P, JONES P, GIURINI JM, ET AL: Percent change in wound area of diabetic foot ulcers over a 4-week period is a robust predictor of complete healing in a 12-week prospective trial. Plast Reconstr Surg 117 (suppl): 239S, 2006.